Paid Clinical Trials Kansas City
Discover 57 paid clinical trials in Kansas City, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Immunotherapy with SurgeryComparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Sponsor:
SWOG Cancer Research Network
Location:
Code:
NCT04510597
Conditions
Metastatic Clear Cell Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma
Stage IV Renal Cell Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cytoreductive Nephrectomy
Active Comparator
BiomarkersUsing Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
Sponsor:
ECOG-ACRIN Cancer Research Group
Location:
Code:
NCT04462406
Conditions
Advanced Melanoma
Clinical Stage III Cutaneous Melanoma AJCC v8
Clinical Stage IV Cutaneous Melanoma AJCC v8
Melanoma of Unknown Primary
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ipilimumab
Nivolumab
Patient Observation
Pembrolizumab
Observational StudyEvaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Sponsor:
ECOG-ACRIN Cancer Research Group
Location:
Code:
NCT06002828
Conditions
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Quality-of-Life Assessment
Questionnaire Administration
Daratumumab, Bortezomib, Lenalidomide, DexamethasoneTesting the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Sponsor:
ECOG-ACRIN Cancer Research Group
Location:
Code:
NCT04566328
Conditions
Plasma Cell Myeloma
RISS Stage I Plasma Cell Myeloma
RISS Stage II Plasma Cell Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bortezomib
Daratumumab and Hyaluronidase-fihj
Dexamethasone
Lenalidomide
Quality-of-Life Assessment
Apalutamide & Targeted RadiationTreating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Sponsor:
ECOG-ACRIN Cancer Research Group
Location:
Code:
NCT04423211
Conditions
Biochemically Recurrent Prostate Carcinoma
Metastatic Prostate Carcinoma
Prostate Adenocarcinoma
Stage IVB Prostate Cancer AJCC v8
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
3-Dimensional Conformal Radiation Therapy
Apalutamide
Computed Tomography
Degarelix
External Beam Radiation Therapy
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Drug CombinationsComparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Sponsor:
SWOG Cancer Research Network
Location:
Code:
NCT05561387
Conditions
Plasma Cell Myeloma
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Bortezomib
Daratumumab and Hyaluronidase-fihj
Dexamethasone
Lenalidomide
Quality-of-Life Assessment
Radiotherapy & ChemotherapyTesting the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body
Sponsor:
ECOG-ACRIN Cancer Research Group
Location:
Code:
NCT04248452
Conditions
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
Clinical Stage IV Gastric Cancer AJCC v8
Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8
Clinical Stage IVA Gastric Cancer AJCC v8
Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Capecitabine
Fluorouracil
Leucovorin
Leucovorin Calcium
Oxaliplatin
Green TeaTo Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring
Sponsor:
ECOG-ACRIN Cancer Research Group
Location:
Code:
NCT04597359
Conditions
Prostate Carcinoma
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Not accepted
Interventions
Placebo Administration
Quality-of-Life Assessment
Questionnaire Administration
Sinecatechins
Carboplatin with IohexolEvaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Sponsor:
NRG Oncology
Location:
Code:
NCT03997370
Conditions
Malignant Solid Neoplasm
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Carboplatin
Iohexol
Encorafenib & BinimetinibA Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Sponsor:
SWOG Cancer Research Network
Location:
Code:
NCT04511013
Conditions
Acral Lentiginous Melanoma
Clinical Stage IV Cutaneous Melanoma AJCC v8
Metastatic Cutaneous Melanoma
Metastatic Malignant Neoplasm in the Brain
Metastatic Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Binimetinib
Encorafenib
Ipilimumab
Nivolumab